Mobiquity Technologies, Inc.
US ˙ OTCPK ˙ US60743F6079

SecurityMOBQ / Mobiquity Technologies, Inc.
InsiderGene Salkind
This page shows the track record and history of Salkind Gene insider trades in Mobiquity Technologies, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Gene Salkind in MOBQ / Mobiquity Technologies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2019-09-13 35,000,000 0.0096 168,675 1.9920 336,000 364 7.8000 979,657 291.56
2019-09-13 127,500,000 0.0185 614,458 3.8387 2,358,750
2019-09-13 12,500,000 0.0400 60,241 8.3000 500,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MOBQ / Mobiquity Technologies, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Gene Salkind in MOBQ / Mobiquity Technologies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MOBQ / Mobiquity Technologies, Inc. Insider Trades
Insider Transaction History
File
Date		 Trade
Date		 Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price		 Unit
Price		 Units
Changed		 Value
Changed (1K)		 Remaining
Options		 Remaining
Shares
2025-09-19 2025-09-15 4 Salkind Gene MOBQ Common Stock A - Award D 1.0000 25,000 25 8,668,695
2025-01-02 2024-12-30 4 Salkind Gene MOBQ Common Stock X - Other D 0.5000 420,000 210 8,643,695
2024-08-22 2024-08-06 4/A Salkind Gene MOBQ Common Stock C - Conversion D 0.2000 7,675,160 1,535 8,223,695
2024-08-08 2024-08-06 4 Salkind Gene MOBQ Common Stock C - Conversion D 0.2000 7,675,160 1,535 8,223,695
2023-11-09 2023-10-06 4/A Salkind Gene MOBQ Common Stock A - Award D 0.6500 150,000 98 448,535
2023-10-10 2023-10-06 4 Salkind Gene MOBQ Common Stock A - Award D 0.6500 150,000 98 448,535
2023-04-13 2023-04-12 4 Salkind Gene MOBQ Common Stock A - Award D 0.1700 1,385,663 236 4,478,017
2023-04-06 2023-04-06 4 Salkind Gene MOBQ Common Stock A - Award D 0.1670 130,000 22 3,092,354
2022-07-05 2022-06-30 4 Salkind Gene MOBQ Common Stock C - Conversion D 1.2500 408,000 510 2,992,354
2022-03-31 2022-03-30 4 Salkind Gene MOBQ Warrants C - Conversion D 4.00 684,166 1,237,500
2022-03-31 2022-03-30 4 Salkind Gene MOBQ Notes C - Conversion D 1.50 127,500
2022-03-31 2022-03-30 4 Salkind Gene MOBQ Common Stock C - Conversion D 1.5000 1,368,333 2,052 2,484,354
2021-12-10 2021-12-08 4 Salkind Gene MOBQ Common Stock Options A - Award D 4.56 35,000 1,422,500
2021-10-04 2021-09-30 4 Salkind Gene MOBQ Common Stock Purchase Warrants M - Exercise D 48.00 375,000 1,387,500
2021-10-04 2021-09-30 4 Salkind Gene MOBQ Preferred Stock M - Exercise D -1,500 1,012,500
2021-10-04 2021-09-30 4 Salkind Gene MOBQ Common Stock M - Exercise D 375,000 1,116,021
2021-04-01 2021-04-01 4 Salkind Gene MOBQ Notes A - Award D 4.00 150,000 1,684,375
2020-09-09 2020-09-08 4 Salkind Gene MOBQ Common Stock A - Award D 0.0100 15,000,000 150 296,318,355
2020-08-04 2020-07-21 4 Salkind Gene MOBQ Common Stock A - Award D 0.0100 15,000,000 150 281,318,355
2020-01-21 2019-09-13 4/A Salkind Gene MOBQ Notes A - Award D 0.08 2,300,000 341,502,500
2020-01-21 2019-09-13 4/A Salkind Gene MOBQ Common Stock P - Purchase D 0.0400 12,500,000 500 266,318,355
2020-01-21 2019-09-13 4/A Salkind Gene MOBQ Common Stock P - Purchase D 0.0185 127,500,000 2,359 253,818,355
2020-01-21 2019-09-13 4/A Salkind Gene MOBQ Common Stock P - Purchase D 0.0096 35,000,000 336 126,318,355
2019-09-19 2019-09-13 4 Salkind Gene MOBQ Notes A - Award D 0.08 2,300,000 341,502,500
2019-09-19 2019-09-13 4 Salkind Gene MOBQ Common Stock P - Purchase D 0.0400 12,500,000 500 266,318,355
2019-09-19 2019-09-13 4 Salkind Gene MOBQ Common Stock P - Purchase D 0.0185 127,500,000 2,359 253,818,355
2019-09-19 2019-09-13 4 Salkind Gene MOBQ Common Stock P - Purchase D 0.0096 35,000,000 336 126,318,355
2019-07-29 2019-07-19 4 Salkind Gene MOBQ Warrants A - Award D 0.12 1,562,500 312,812,500
2019-07-29 2019-07-19 4 Salkind Gene MOBQ Common Stock A - Award D 0.0800 3,125,000 250 91,318,355
2019-07-29 2019-07-14 4 Salkind Gene MOBQ Common Stock A - Award D 0.0400 12,500,000 500 88,193,355
2019-07-29 2019-06-18 4 Salkind Gene MOBQ Warrants A - Award D 0.12 1,562,500 311,250,000
2019-07-29 2019-06-18 4 Salkind Gene MOBQ Common Stock A - Award D 0.0800 3,125,000 250 75,693,355
2019-05-22 2019-05-03 4 Salkind Gene MOBQ Warrants A - Award D 0.12 3,437,500 309,687,500
2019-05-22 2019-05-03 4 Salkind Gene MOBQ Common Stock A - Award D 0.0800 6,875,000 550 72,658,355
2019-04-04 2019-04-03 4 Salkind Gene MOBQ Warrants A - Award D 0.12 6,250,000 306,250,000
2019-04-04 2019-04-03 4 Salkind Gene MOBQ Common Stock A - Award D 0.0800 12,500,000 1,000 65,783,355
2019-02-26 2019-01-14 4 Salkind Gene MOBQ Convertible Notes X - Other D 0.02 -1,000,000 300,000,000
2019-02-26 2019-01-14 4 Salkind Gene MOBQ Common Stock X - Other D 0.0200 50,000,000 1,000 53,283,355
2019-02-26 3 Salkind Gene MOBQ Common Stock D 6,566,710
2019-02-26 3 Salkind Gene MOBQ Common Stock D 6,566,710
2019-02-26 3 Salkind Gene MOBQ Common Stock D 6,566,710
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)